|
Volumn 110, Issue 6, 1995, Pages 1658-1662
|
Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APROTININ;
CD11B ANTIGEN;
METHYLPREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AGED;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CARDIOPULMONARY BYPASS;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FLUORESCENCE ACTIVATED CELL SORTER;
HUMAN;
INFLAMMATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NEUTROPHIL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
AGED;
ANTI-INFLAMMATORY AGENTS;
APROTININ;
CARDIOPULMONARY BYPASS;
CORONARY ARTERY BYPASS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
HUMANS;
INFLAMMATION;
MACROPHAGE-1 ANTIGEN;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
NEUTROPHILS;
SURGICAL PROCEDURES, ELECTIVE;
TIME FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0028972012
PISSN: 00225223
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-5223(95)70027-7 Document Type: Article |
Times cited : (221)
|
References (35)
|